Published in Nephrol Dial Transplant on December 01, 1998
Dipstick urine analysis screening among asymptomatic school children. N Am J Med Sci (2011) 1.07
Urinary screening for detection of renal abnormalities in asymptomatic school children. Nephrourol Mon (2012) 1.02
Survival patterns of patients on maintenance hemodialysis for end stage renal disease in Ethiopia: summary of 91 cases. BMC Nephrol (2013) 0.83
Screening for kidney disease in children on World Kidney Day in Jalisco, Mexico. Pediatr Nephrol (2009) 0.82
The global burden of disease and the challenge of invisibility. Nephrol Dial Transplant (1998) 0.75
Clinical and epidemiological programme on renal disease. Nephrol Dial Transplant (1999) 0.75
Assessment of the 10-year risk of cardiovascular disease among a group of patients on maintenance hemodialysis: A cross-sectional study from Cameroon. JRSM Cardiovasc Dis (2017) 0.75
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Lessons from the Di Bella affair. Lancet (1999) 11.68
Comparison of the genomes of two Xanthomonas pathogens with differing host specificities. Nature (2002) 8.42
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med (2013) 7.51
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med (2001) 6.22
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med (1998) 6.17
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet (1999) 4.38
Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell (2000) 3.54
Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature (2000) 3.51
Health services: an Italian market. Lancet (1996) 3.43
Progression, remission, regression of chronic renal diseases. Lancet (2001) 3.17
Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity? Lancet (1978) 3.15
Hedgehog induces opposite changes in turnover and subcellular localization of patched and smoothened. Cell (2000) 3.10
Modulating the profit motive to meet needs of the less-developed world. Lancet (2001) 2.86
A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int (2006) 2.85
Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol (1995) 2.73
Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med (1993) 2.70
Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Int J Tuberc Lung Dis (2007) 2.68
The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. J Am Soc Nephrol (2001) 2.56
Strategies for making more organs available for transplantation. N Engl J Med (2000) 2.48
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int (2001) 2.43
Mecrowear of mammalian teeth as an indicator of diet. Science (1978) 2.24
Factor H family proteins: on complement, microbes and human diseases. Biochem Soc Trans (2002) 2.23
Inhibition of TGF-beta expression: a novel role for thiazolidinediones to implement renoprotection in diabetes. Kidney Int (2007) 2.19
Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A. Virology (1992) 2.18
Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int (2006) 2.18
Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol (2001) 2.16
Endoscopic diagnosis and treatment of an esophageal bezoar resulting from bulk laxative ingestion. Endoscopy (1994) 2.14
ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney Int (2006) 2.05
Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia (2011) 2.00
Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond) (2011) 2.00
Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Kidney Int (1998) 1.99
Takayasu's arteritis: A study of 104 Italian patients. Arthritis Rheum (2005) 1.94
Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest (1982) 1.90
Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest (1998) 1.87
Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int (2001) 1.77
Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res (1995) 1.73
Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes. J Biol Chem (1999) 1.72
Clinical correlates of interferon gamma production in patients with tuberculosis. Clin Infect Dis (1997) 1.70
Testing an intervention to prevent further abuse to pregnant women. Res Nurs Health (1999) 1.67
Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int (1998) 1.66
Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. Am J Transplant (2006) 1.66
Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease. J Am Soc Nephrol (1998) 1.64
Cyclosporin-induced endothelial cell injury. Lab Invest (1986) 1.60
Heterogeneous nature of renal lesions in type II diabetes. J Am Soc Nephrol (1993) 1.59
Tissue plasminogen activator therapy of rabbit nephrotoxic nephritis. Lab Invest (1990) 1.56
Time to abandon microalbuminuria? Kidney Int (2006) 1.56
Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy. Kidney Int (1998) 1.55
Neurological symptoms and coma associated with doxorubicin administration during chronic cyclosporin therapy. Lancet (1992) 1.54
Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation (1999) 1.54
An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer. Rev Port Pneumol (2008) 1.53
Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura. J Am Soc Nephrol (1999) 1.53
Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol (1989) 1.51
Thrombotic microangiopathy after kidney transplantation. Am J Transplant (2010) 1.44
Sequence of glomerular changes in experimental endotoxemia: a possible model of hemolytic uremic syndrome. Nephron (1989) 1.43
Prostacyclin and human foetal circulation. Prostaglandins (1979) 1.42
[Characterization of a Portuguese population with systemic lupus erytematosus]. Acta Reumatol Port (2007) 1.42
ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy. J Am Soc Nephrol (2001) 1.42
Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Am J Pathol (1991) 1.41
Endoscopic myotomy in the treatment of achalasia. Gastrointest Endosc (1980) 1.39
Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med (1983) 1.38
Immunomodulation by intrathymic injection of donor leukocytes in rhesus monkeys. Transplantation (2001) 1.37
Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. Am J Transplant (2006) 1.37
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). J Renin Angiotensin Aldosterone Syst (2000) 1.35
Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans. J Mol Med (Berl) (2009) 1.33
Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins (1980) 1.33
Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am J Kidney Dis (2000) 1.31
PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine. Circulation (1998) 1.31
Validation of endogenous control genes in human adipose tissue: relevance to obesity and obesity-associated type 2 diabetes mellitus. Horm Metab Res (2007) 1.31
Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL. Kidney Int (2006) 1.30
Drug-induced thrombotic microangiopathy: incidence, prevention and management. Drug Saf (2001) 1.29
Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes. Int J Obes (Lond) (2009) 1.28
Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet (1982) 1.27
Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int (1997) 1.27
5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2009) 1.26
Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant. Transplantation (2000) 1.24
Severity of abuse to pregnant women and associated gun access of the perpetrator. Public Health Nurs (1998) 1.23
Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest (1990) 1.23
Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol (2001) 1.22
Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1. J Lab Clin Med (1992) 1.22
Complete amino acid sequence of flavocytochrome b2 from baker's yeast. Eur J Biochem (1985) 1.22
Fluid shear stress modulates von Willebrand factor release from human vascular endothelium. Blood (1997) 1.21
Endothelin antagonists. Lancet (1999) 1.20
Safety behaviors of abused women after an intervention during pregnancy. J Obstet Gynecol Neonatal Nurs (1998) 1.20
Fluid shear stress modulates surface expression of adhesion molecules by endothelial cells. Blood (1995) 1.19
Expression of the Rous sarcoma virus env gene from a simian virus 40 late-region replacement vector: effects of upstream initiation codons. J Virol (1987) 1.18
Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int (1990) 1.17
A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int (1993) 1.17
Sex related differences in glomerular ultrafiltration and proteinuria in Munich-Wistar rats. Kidney Int (1988) 1.17
In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol (1998) 1.16
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev (2004) 1.15
Nonviral gene delivery to the rat kidney with polyethylenimine. Hum Gene Ther (1997) 1.13
Recent progress in the pathophysiology and treatment of FSGS recurrence. Am J Transplant (2013) 1.13
Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. Am J Transplant (2007) 1.12
Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis (1995) 1.12
Resource use by abused women following an intervention program: associated severity of abuse and reports of abuse ending. Public Health Nurs (1997) 1.12